Nearly half of drugmakers didn’t report safety issues to FDA, report finds

From 2018 to 2021, 49.1 percent of global pharmaceutical companies selling products in the U.S. did not submit field alert reports, which are required to be sent to the FDA within three days of a potential defect or safety issue, according to an agency report. 

Advertisement

Nearly two-thirds of foreign drug manufacturers and 38.9 percent of domestic facilities failed to submit FARs during the four-year period, the FDA’s Office of Pharmaceutical Quality found.

Although most of the sites handled non-sterile products, the missing FAR reports can include anything from a mislabeled batch to bacterial contamination. 

The report did not specify which facilities failed to alert the FDA about potential safety problems.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.